Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-11-001006
Filing Date
2011-03-30
Accepted
2011-03-30 17:03:07
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 PERIOD ENDED DECEMBER 31, 2010 ptx_10k.htm 10-K 2289388
2 AMENDED AND RESTATED EMPLOYMENT NON-COMPETE AGREEMENT ptx_ex106.htm EX-10.6 663910
3 STOCK PURCHASE AGREEMENT ptx_ex1012.htm EX-10.12 226028
4 SUBSIDIARIES OF THE COMPANY ptx_ex211.htm EX-21.1 2428
5 CONSENT OF CHERRY, BEKAERT & HOLLAND L.L.P ptx_ex231.htm EX-23.1 3277
6 CERTIFICATION ptx_ex311.htm EX-31.1 11000
7 CERTIFICATION ptx_ex312.htm EX-31.2 11000
8 CERTIFICATION ptx_ex321.htm EX-32.1 6989
  Complete submission text file 0001354488-11-001006.txt   3215117
Mailing Address 33219 FOREST WEST STREET MAGNOLIA TX 77354
Business Address 33219 FOREST WEST STREET MAGNOLIA TX 77354 (832) 934-1825
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14494 | Film No.: 11722800
SIC: 2834 Pharmaceutical Preparations